Organisation paid for research Program year 2025 Source: CMS Open Payments

UPMC Urology Department

Neither a doctor nor a teaching hospital

Research payments

$953

8 payments

Through program year 2025, UPMC Urology Department is reported as receiving $953 in research payments, across 8 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $312 7
2024 Research $641 1

Breakdown

Who paid Research payments · program years 2024–2025
  1. Boehringer Ingelheim Pharma GmbH & Co.KG $953 8 payments
Studies the money was for Research payments · program years 2024–2025
  1. FIH Dose escalation ph1 DLL3 pos SCLC and other NEC $641 1 payment
  2. DAREON-5: An open-label, multi-center Phase II dose selection trial of intravenous BI 764532, a DLL3-targeting T cell engager, in patients with relapsed/refractory extensive-stage small cell lung cancer and in patients with other relapsed/refractory neuroendocrine carcinomas $312 7 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record